Financials
Income statement
| Fiscal date | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
|---|---|---|---|---|
| Total reported revenue | 10.1B | 8.8B | 8.8B | 5.2B |
| Cost of revenue | 6.9B | 6.7B | 9.3B | 6.3B |
| Gross profit | 3.2B | 2.2B | -449.6M | -1.1B |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 7.0B | 3.4B | 3.3B | 4.1B |
| Other operating expenses | — | 502.0M | 635.4M | — |
| Operating income | -3.8B | -3.1B | -6.9B | -5.2B |
| Non operating interest income | ||||
| Income | 62.0M | 49.7M | 93.5M | 92.9M |
| Expense | 3.0B | 574.1M | 2.6B | 893.8M |
| Other income expense | — | — | — | — |
| Pretax income | 798.5M | 1.0B | -3.3B | -2.5B |
| Tax provision | 1.7B | 2.2B | -198.6M | 22.1M |
| Net income | -945.1M | -1.2B | -3.1B | -2.5B |
| Basic EPS | -0.4 | -0.5 | — | -1.0 |
| Diluted EPS | -0.4 | -0.5 | — | -1.0 |
| Basic average shares | 2.5B | 2.5B | — | 2.5B |
| Diluted average shares | 2.5B | 2.5B | — | 2.5B |
| EBITDA | 6.0B | 4.0B | 2.9B | -544.8M |
| Net income from continuing op. | -1.1B | -1.2B | -3.1B | -498.3M |
| Minority interests | 0 | — | 0 | 0 |
| Preferred stock dividends | 0 | 0 | 0 | 0 |